PRPH Stock Price, Chart, Stats & News
ProPhase Labs, Inc. (PRPH) does not currently pay a dividend.
PRPH chart
Fundamentals
Gross margin | 191.36% |
Operating margin | -2496.56% |
Pretax margin | -2909.10% |
Net margin | -3872.24% |
Effective tax rate | -48.44% |
ROA | -63.47% |
ROE | -404.42% |
D/E | 1.12x |
Interest coverage ratio | -7.25x |
PRPH valuation
P/E | – |
P/S | 0.31x |
P/B | 0.04x |
P/CF | -0.01x |
P/FCF | -0.01x |
P/OCF | -0.01x |
PEG | -0.00x |
EV multiple | 0.28x |
About
ProPhase Labs, Inc., founded in 1989 in Garden City, New York (and previously known as The Quigley Corporation), operates as a diversified company with two main areas of focus: Consumer Products and Diagnostic Services. Through its Consumer Products division, ProPhase Labs is actively involved in the entire process—from researching and developing to manufacturing, distributing, marketing, and selling—a range of over-the-counter (OTC) healthcare items and nutritional supplements within the United States. Notable offerings include dietary supplements like Legendz XL, which supports male sexual health, and Triple Edge XL, formulated to enhance energy and stamina.
Similar securities
Based on sector and market capitalization
